(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.36% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.8%.
Revvity's revenue in 2025 is $2,798,467,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $330,578,190,017, with the lowest RVTY revenue forecast at $329,727,378,006, and the highest RVTY revenue forecast at $331,492,841,948. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $344,015,680,459, with the lowest RVTY revenue forecast at $340,348,019,076, and the highest RVTY revenue forecast at $346,685,581,944.
In 2027, RVTY is forecast to generate $367,281,500,539 in revenue, with the lowest revenue forecast at $363,202,710,078 and the highest revenue forecast at $370,018,491,976.